JAIME STONE: Open Payments
NPI 1417432303 · CLAREMONT, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,736 in 80 payments from 18 companies in 2025. Trend: 2023 $958 · 2024 $862 · 2025 $1,736
Food & beverage: $1,736
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $444 |
| ABBVIE INC. | 20 | $378 |
| Novo Nordisk Inc | 8 | $171 |
| Amgen Inc. | 7 | $157 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| PFIZER INC. | 3 | $79 |
| Astellas Pharma US Inc | 3 | $72 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| Vanda Pharmaceuticals Inc. | 2 | $57 |
| Exact Sciences Corporation | 2 | $51 |
Products named: AIRSUPRA, OTEZLA, QULIPTA, BREZTRI, UBRELVY, VRAYLAR, Ozempic, REXULTI.
Industry payments across NH — which companies pay providers there.
